Peter Makhov
Impact in
- Pharmacology top 2%
- Piperaceae Chemical and Biological Studies
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
Papers in
-
- Cell death mechanisms and regulation 2
-
- Renal cell carcinoma treatment 5
- Prostate Cancer Treatment and Research 4
- Co-authors
- Vladimir Kolenko (32 shared papers)Robert G. Uzzo (27 shared papers)Alexander Kutikov (16 shared papers)Konstantin Golovine (21 shared papers)Pooja Ghatalia (1 shared paper)Shreyas Joshi (1 shared paper)Daniel Canter (10 shared papers)Paul L. Crispen (4 shared papers)
- Journals
- The Prostate (5 papers)British Journal of Cancer (3 papers)The Journal of Urology (3 papers)Cancers (3 papers)Urology (2 papers)
- Partner nations
- United StatesRussiaItaly
In The Last Decade
Peter Makhov
34 papers receiving 1.3k citations
Peter Makhov's Hit Papers
Peers
Comparison fields: 5 of 85
- Pharmacology 205
- Cancer Research 251
- Pulmonary and Respiratory Medicine 358
- Nutrition and Dietetics 172
- Oncology 246
Countries citing papers authored by Peter Makhov
This map shows the geographic impact of Peter Makhov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Makhov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Makhov more than expected).
Fields of papers citing papers by Peter Makhov
This network shows the impact of papers produced by Peter Makhov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Makhov. The network helps show where Peter Makhov may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Makhov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies Hit paper breakdown → | 2018 | 365 |
| 2 | 2011 | 105 | |
| 3 | 2014 | 103 | |
| 4 | 2012 | 78 | |
| 5 | 2005 | 69 | |
| 6 | 2008 | 62 | |
| 7 | 2008 | 61 | |
| 8 | 2012 | 57 | |
| 9 | 2008 | 54 | |
| 10 | 2007 | 46 | |
| 11 | 2018 | 40 | |
| 12 | 2016 | 36 | |
| 13 | 2015 | 34 | |
| 14 | 2017 | 29 | |
| 15 | 2010 | 25 | |
| 16 | 2019 | 24 | |
| 17 | 2011 | 22 | |
| 18 | 2020 | 20 | |
| 19 | 2011 | 20 | |
| 20 | 2008 | 16 |
About Peter Makhov
Peter Makhov is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Nutrition and Dietetics, Oncology and Pharmacology, having authored 34 papers that have together received 1.3k indexed citations. Recurring topics across this work include Trace Elements in Health (7 papers), PARP inhibition in cancer therapy (6 papers), Renal cell carcinoma treatment (5 papers), Piperaceae Chemical and Biological Studies (5 papers), Cancer, Lipids, and Metabolism (4 papers), Prostate Cancer Treatment and Research (4 papers), Cancer Genomics and Diagnostics (2 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Pharmacology (205 citations), Cancer Research (251 citations), Pulmonary and Respiratory Medicine (358 citations), Nutrition and Dietetics (172 citations) and Oncology (246 citations). Peter Makhov has collaborated with scholars based in United States, Russia and Italy. Frequent co-authors include Vladimir Kolenko, Robert G. Uzzo, Alexander Kutikov, Konstantin Golovine, Pooja Ghatalia, Shreyas Joshi, Daniel Canter, Paul L. Crispen, Ervin Teper and Alexei V. Tulin. Their work appears in journals such as The Prostate, British Journal of Cancer, The Journal of Urology, Cancers and Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.